Gout
REstream Block (Upcoming)
What's New in Calcium Pyrophosphate Disease? with Dr. Michael Pillinger
NYU's Dr. Pillinger talks about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at ACR 2020.
Who has more comorbidities? Dr. Janet Pope
Dr. Janet Pope reviews abstract #1466 presented at the 2020 ACR annual meeting. Who has more comorbidities: OA, Gout, RA or PsA?
Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis
Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.
Comorbidities in Gout with Dr. Nicola Dalbeth
Dr. Dalbeth examines abstracts #1466 and #0660 relating to the comorbidities in Gout at ACR 2020.
Roundtable on Gout: What's Hot at ACR 2020 with Gout Faculty
Drs. Michael Pillinger, Naomi Schlesinger and Robert Keenan discuss the hot topics in Gout in a panel discussion at ACR 2020.
3 years 10 months ago
Read my #ACR20 article on diet as a mechanism to control gout @rheumnow https://t.co/nEWJqt8eXx
3 years 10 months ago
Poll results are in! Most would like to wait for a phase III before prescribing MMF with pegloticase in refractory gout. @RheumNow #ACR20 https://t.co/45MpFliDkE
Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger
Dr. Pillinger reviews abstract #0675 and #0690 presented at the 2020 ACR annual meeting.
3 years 10 months ago
Dr McCormick presents on causal association between hyperuricaemia and diabetes. Insulin resistance causal for high urate. Target insulin resistance to prevent gout. @rheumnow #ACR20 Abstr#1472 https://t.co/OSr3ktIXSS
3 years 10 months ago
#Multimorbidity in #RheumaticDisease: Abs#1466:
-Highly prevalent across RA, PsA, gout & OA
-Highest burden in #gout
Important study highlighting need to recognise burden of MM in #rheumatology patients for holistic optimised management.
#ACR20 @RheumNow
https://t.co/esinnHoUME https://t.co/bApXfx7hOU
Poster Hall